This page shows Marten Trans (MRTN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Marten Trans has an operating margin of 2.6%, meaning the company retains $3 of operating profit per $100 of revenue. This below-average margin results in a low score of 28/100, suggesting thin profitability after operating expenses. This is down from 3.5% the prior year.
Marten Trans's revenue declined 8.3% year-over-year, from $963.7M to $883.7M. This contraction results in a growth score of 19/100.
Marten Trans carries a low D/E ratio of 0.24, meaning only $0.24 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.
Marten Trans's current ratio of 1.86 indicates adequate short-term liquidity, earning a score of 33/100. The company can meet its near-term obligations, though with limited headroom.
Marten Trans generates a 2.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 16/100. This is down from 3.5% the prior year.
Marten Trans scores 5.86, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.1B) relative to total liabilities ($182.1M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Marten Trans passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Marten Trans generates $5.36 in operating cash flow ($93.5M OCF vs $17.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Marten Trans generated $883.7M in revenue in fiscal year 2025. This represents a decrease of 8.3% from the prior year.
Marten Trans's EBITDA was $128.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 11.4% from the prior year.
Marten Trans reported $17.4M in net income in fiscal year 2025. This represents a decrease of 35.2% from the prior year.
Marten Trans earned $0.21 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 36.4% from the prior year.
Cash & Balance Sheet
Marten Trans held $43.3M in cash against $0 in long-term debt as of fiscal year 2025.
Marten Trans paid $0.24 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Marten Trans had 82M shares outstanding in fiscal year 2025. This represents an increase of 0.1% from the prior year.
Margins & Returns
Marten Trans's operating margin was 2.6% in fiscal year 2025, reflecting core business profitability. This is down 0.9 percentage points from the prior year.
Marten Trans's net profit margin was 2.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.8 percentage points from the prior year.
Marten Trans's ROE was 2.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.2 percentage points from the prior year.
Capital Allocation
MRTN Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $210.1M-4.7% | $220.5M-4.1% | $229.9M+3.0% | $223.2M-3.2% | $230.4M-2.9% | $237.4M-3.6% | $246.2M-1.4% | $249.7M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $4.6M+67.3% | $2.7M-71.9% | $9.7M+66.1% | $5.9M-12.9% | $6.7M+57.6% | $4.3M-57.2% | $10.0M-18.6% | $12.3M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $1.4M+86.3% | $725K-75.7% | $3.0M+59.3% | $1.9M+25.9% | $1.5M+3.5% | $1.4M-53.6% | $3.1M-8.9% | $3.4M |
| Net Income | $3.7M+66.1% | $2.2M-69.0% | $7.2M+65.8% | $4.3M-23.0% | $5.6M+50.1% | $3.8M-52.4% | $7.9M-18.2% | $9.6M |
| EPS (Diluted) | N/A | $0.03-66.7% | $0.09+80.0% | $0.05 | N/A | $0.05-50.0% | $0.10-16.7% | $0.12 |
MRTN Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $949.8M-2.7% | $975.7M-1.6% | $991.8M+0.9% | $983.3M+1.5% | $968.8M-3.1% | $1.0B-1.0% | $1.0B+1.7% | $993.0M |
| Current Assets | $171.7M-2.4% | $176.0M+13.0% | $155.8M-4.1% | $162.5M+17.3% | $138.5M-18.7% | $170.3M-22.5% | $219.6M+2.6% | $214.0M |
| Cash & Equivalents | $43.3M-12.5% | $49.5M+41.2% | $35.1M-12.2% | $39.9M+131.1% | $17.3M-59.8% | $43.0M-44.3% | $77.2M+4.7% | $73.7M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $85.8M-6.7% | $92.0M+0.6% | $91.4M-4.0% | $95.3M+5.8% | $90.0M-3.8% | $93.5M-6.4% | $99.9M-5.1% | $105.2M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $182.1M-12.2% | $207.5M-6.2% | $221.1M+2.4% | $215.8M+7.5% | $200.8M-14.0% | $233.5M-3.9% | $243.1M+5.4% | $230.6M |
| Current Liabilities | $92.2M-20.2% | $115.6M-0.9% | $116.7M+6.4% | $109.6M+17.2% | $93.5M-19.9% | $116.7M-1.9% | $119.0M+6.8% | $111.4M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $767.6M-0.1% | $768.2M-0.3% | $770.7M+0.4% | $767.5M-0.1% | $767.9M+0.2% | $766.5M0.0% | $766.8M+0.6% | $762.4M |
| Retained Earnings | $712.0M-0.2% | $713.2M-0.4% | $715.9M+0.3% | $713.6M-0.1% | $714.2M+0.1% | $713.4M-0.2% | $714.6M+0.4% | $711.5M |
MRTN Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.6M-69.9% | $18.5M-44.1% | $33.2M-8.5% | $36.2M+52.2% | $23.8M-19.3% | $29.5M-17.7% | $35.8M-21.7% | $45.7M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$7.1M-223.3% | $5.8M+117.5% | -$33.1M-293.6% | -$8.4M+81.3% | -$44.9M+24.2% | -$59.2M-113.2% | -$27.8M-37.2% | -$20.2M |
| Financing Cash Flow | -$4.7M+4.8% | -$4.9M0.0% | -$4.9M+5.3% | -$5.2M-11.7% | -$4.6M-3.6% | -$4.5M+2.4% | -$4.6M+7.7% | -$5.0M |
| Dividends Paid | $4.9M0.0% | $4.9M0.0% | $4.9M0.0% | $4.9M0.0% | $4.9M+0.1% | $4.9M0.0% | $4.9M+0.1% | $4.9M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
MRTN Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 2.2%+0.9pp | 1.2%-3.0pp | 4.2%+1.6pp | 2.6%-0.3pp | 2.9%+1.1pp | 1.8%-2.3pp | 4.0%-0.9pp | 4.9% |
| Net Margin | 1.8%+0.8pp | 1.0%-2.1pp | 3.1%+1.2pp | 1.9%-0.5pp | 2.4%+0.9pp | 1.6%-1.6pp | 3.2%-0.7pp | 3.9% |
| Return on Equity | 0.5%+0.2pp | 0.3%-0.6pp | 0.9%+0.4pp | 0.6%-0.2pp | 0.7%+0.2pp | 0.5%-0.5pp | 1.0%-0.2pp | 1.3% |
| Return on Assets | 0.4%+0.2pp | 0.2%-0.5pp | 0.7%+0.3pp | 0.4%-0.1pp | 0.6%+0.2pp | 0.4%-0.4pp | 0.8%-0.2pp | 1.0% |
| Current Ratio | 1.86+0.3 | 1.52+0.2 | 1.34-0.1 | 1.480.0 | 1.48+0.0 | 1.46-0.4 | 1.85-0.1 | 1.92 |
| Debt-to-Equity | 0.24-0.0 | 0.27-0.0 | 0.290.0 | 0.28+0.0 | 0.26-0.0 | 0.30-0.0 | 0.32+0.0 | 0.30 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Marten Trans's annual revenue?
Marten Trans (MRTN) reported $883.7M in total revenue for fiscal year 2025. This represents a -8.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Marten Trans's revenue growing?
Marten Trans (MRTN) revenue declined by 8.3% year-over-year, from $963.7M to $883.7M in fiscal year 2025.
Is Marten Trans profitable?
Yes, Marten Trans (MRTN) reported a net income of $17.4M in fiscal year 2025, with a net profit margin of 2.0%.
What is Marten Trans's EBITDA?
Marten Trans (MRTN) had EBITDA of $128.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Marten Trans's operating margin?
Marten Trans (MRTN) had an operating margin of 2.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Marten Trans's net profit margin?
Marten Trans (MRTN) had a net profit margin of 2.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Marten Trans pay dividends?
Yes, Marten Trans (MRTN) paid $0.24 per share in dividends during fiscal year 2025.
What is Marten Trans's return on equity (ROE)?
Marten Trans (MRTN) has a return on equity of 2.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Marten Trans's operating cash flow?
Marten Trans (MRTN) generated $93.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Marten Trans's total assets?
Marten Trans (MRTN) had $949.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Marten Trans's current ratio?
Marten Trans (MRTN) had a current ratio of 1.86 as of fiscal year 2025, which is generally considered healthy.
What is Marten Trans's debt-to-equity ratio?
Marten Trans (MRTN) had a debt-to-equity ratio of 0.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Marten Trans's return on assets (ROA)?
Marten Trans (MRTN) had a return on assets of 1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Marten Trans's Altman Z-Score?
Marten Trans (MRTN) has an Altman Z-Score of 5.86, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Marten Trans's Piotroski F-Score?
Marten Trans (MRTN) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Marten Trans's earnings high quality?
Marten Trans (MRTN) has an earnings quality ratio of 5.36x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Marten Trans?
Marten Trans (MRTN) scores 39 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.